OverviewChartProfileKey statisticsFinancialsTechnicalNews
Derivatives
TraderScreen

Target Corp/  US87612E1064  /

NYSE
24/05/2024  22:10:00 Chg. +0.82 Volume Bid12:35:39 Ask12:35:39 Market Capitalization Dividend Y. P/E Ratio
145.23USD +0.57% 3.55 mill.
Turnover: 358.73 mill.		 145.27Bid Size: 100 146.00Ask Size: 100 67.05 bill.USD 3.02% 16.21
GlobeNewswire 13:10 Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
GlobeNewswire 13:07 Gold Royalty Announces Agreement to Acquire Vares Copper Stream
GlobeNewswire 13:07 Gold Royalty Announces US$30 Million Bought Deal Financing
GlobeNewswire 13:03 Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 a...
GlobeNewswire 13:03 Olema Oncology to Participate in Upcoming Investor Conferences in June
GlobeNewswire 13:02 Golar LNG Limited Interim results for the period ended March 31 2024
GlobeNewswire 13:02 Ocugen Set to Join Russell 3000® Index Effective June 28, 2024
GlobeNewswire 13:02 Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria
GlobeNewswire 13:00 Alpine Income Property Trust Declares Dividend For the Second Quarter 2024
GlobeNewswire 13:00 4AIR Business Aviation Analysis Finds Small Changes to Aircraft Routings Could Reduce Environmental ...
GlobeNewswire 13:00 Mobilicom Secures Another Follow-On Order from the U.S. Defense Industry
GlobeNewswire 13:00 Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management
GlobeNewswire 13:00 Atha Energy Agrees to Terms on $10.7 Million Option Agreement with Riverboat Energy Corporation for ...
GlobeNewswire 13:00 Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice
GlobeNewswire 13:00 Orion Group Holdings Set to Join the Russell 3000® Index
GlobeNewswire 13:00 Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Ps...
GlobeNewswire 13:00 Agios Announces $905 Million Purchase Agreement for Vorasidenib Royalty
GlobeNewswire 13:00 Presenting on the Emerging Growth Metals Mining Resources & Energy Conference on May 29 Register Now
GlobeNewswire 13:00 Nevada Exploration Forms Advisory Board and Appoints Former Uranerz Uranium Professionals
GlobeNewswire 13:00 Merus’ Petosemtamab in Combination with Pembrolizumab Interim Data Demonstrates Robust Response Rate...
GlobeNewswire 13:00 9thCO Crafts Next.js-Powered Online Marketplace for Travel Startup RollDeep
GlobeNewswire 13:00 Ocean Power Technologies Completes Operation with Multiple Unmanned Surface Vehicles for US Governme...
GlobeNewswire 13:00 CTO Realty Growth Declares Dividends For the Second Quarter 2024
GlobeNewswire 13:00 Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June
GlobeNewswire 13:00 BioXcel Therapeutics to Present at Jefferies Global Healthcare Conference